Skip to content

    Brain & Nervous System Health Center

    Font Size

    FDA OKs Generic Requip

    Approval Announced for Generic Versions of Requip Made by 4 Different Companies
    WebMD Health News
    Reviewed by Louise Chang, MD

    May 14, 2008 -- The FDA has approved generic versions of the drug Requip made by four companies.

    Generic ropinirole hydrochloride will be made by Teva Pharmaceuticals USA, Roxane Laboratories, Mylan Pharmaceuticals, and Par Pharmaceutical.

    Requip, made by GlaxoSmithKline, is used to treat restless legs syndrome and Parkinson's disease. Requip's patent expires on May 19, according to the FDA.

    Restless legs syndrome (RLS) is a disorder in which people have an unpleasant feeling in their legs when lying down to sleep; they often have a strong urge to move their legs, making it difficult to sleep.

    Parkinson's is a progressive disease in which there is a breakdown in the nerve cells in the brain that make dopamine. Symptoms include tremors, stiff muscles, slow movement, and problems with balance or walking.

    Today on WebMD

    nerve damage
    Learn how this disease affects the nervous system.
    senior woman with lost expression
    Know the early warning signs.
    woman in art gallery
    Tips to stay smart, sharp, and focused.
    medical marijuana plant
    What is it used for?
    woman embracing dog
    boy hits soccer ball with head
    red and white swirl
    marijuana plant
    brain illustration stroke
    nerve damage
    Alzheimers Overview
    Graphic of number filled head and dna double helix